| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 03/04/1997 | US5608072 Retroviral protease inhibiting compounds |
| 03/04/1997 | US5608045 Disodium salt by pot reacting rhamnose triacetate with phenyl dichlorophosphate in presence of triethylamine and with /s/leu-/s/trp-oet in solvent, saponifying separated product with ethanolic base in cold, evaporating ethanol |
| 03/04/1997 | US5607676 Immunogenic compositions against gastrin peptides |
| 02/27/1997 | WO1997007130A1 Novel opioid peptides |
| 02/27/1997 | WO1997007129A1 Solution synthesis of peripheral acting analgesic opioid tetrapeptides |
| 02/27/1997 | WO1997001579A3 Somatostatin peptides |
| 02/27/1997 | CA2229797A1 Novel opioid peptides |
| 02/26/1997 | EP0759066A1 Process for obtaining micro-organisms containing peptide amidase, micro-organisms obtained therewith, peptide amidases contained in them and use thereof |
| 02/26/1997 | EP0759031A1 Improved method for the preparation of an aspartame-derived compound useful as a sweetener |
| 02/26/1997 | EP0759030A1 N- N-(3,3-DIMETHYLBUTYL)-L-$g(a)-ASPARTYL]-L-HEXAHYDROPHENYLALANINE 1-METHYL ESTER USEFUL AS A SWEETENING AGENT AND METHOD OF PREPARATION |
| 02/26/1997 | EP0758843A1 Modified amino acids for drug delivery |
| 02/26/1997 | EP0697884A4 Ligand precursors for incorporation into peptides |
| 02/26/1997 | EP0630382B1 Lactam dipeptides having hle inhibiting activity |
| 02/26/1997 | CN1143649A Crystallization of alpha-L-aspartyl-L-phenylalanine methyl ester from aqueous solution |
| 02/26/1997 | CN1143648A Novel aspartyldipeptideamide derivatives and sweetener |
| 02/26/1997 | CN1143647A Dipeptides which promote release of growth hormone |
| 02/26/1997 | CN1143496A Improving tolerability of pharmaceutically active beta-amino acids |
| 02/25/1997 | US5606028 Anchimeric radiometal chelating compounds |
| 02/25/1997 | US5605926 Trifluoromethyl-containing pseudopeptides active against retroviruses |
| 02/25/1997 | US5605916 Arylalkyl-amines having anticonvulsant and neuroprotective properties |
| 02/25/1997 | US5605809 Reagents comprising characteristically folded peptide backbone each end of which is conjugated to a fluorophore |
| 02/20/1997 | WO1997006242A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/20/1997 | WO1997005865A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen |
| 02/20/1997 | CA2229098A1 C-proteinase inhibitors for the treatment of disorders related to the overproduction of collagen |
| 02/20/1997 | CA2229044A1 Recombinant c-proteinase and processes, methods and uses thereof |
| 02/19/1997 | EP0758342A1 New peptide active substance and production thereof |
| 02/19/1997 | EP0758341A1 FACTOR Xa INHIBITORS |
| 02/19/1997 | EP0758339A1 Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamidonaphthalene derivatives |
| 02/19/1997 | CN1143075A 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics |
| 02/19/1997 | CN1034054C Preparing method for improved oligosaccharide conjugate vaccines |
| 02/18/1997 | US5604201 Methods and reagents for inhibiting furin endoprotease |
| 02/13/1997 | WO1997005162A1 Process for producing dolastatin 15 and intermediates thereof |
| 02/13/1997 | WO1997005161A1 Boronic acid derivatives |
| 02/13/1997 | WO1997005160A1 Bicyclic lactam derivatives as thrombin inhibitors |
| 02/13/1997 | WO1997005108A1 Penicillaminamide derivatives |
| 02/13/1997 | WO1997005107A1 Serine derivatives |
| 02/13/1997 | WO1996040627A3 Thiocationic lipids, pharmaceutical compositions and methods of use thereof |
| 02/12/1997 | EP0758021A2 Method for determining the therapeutic activity of metalloproteinase inhibitor compounds, new inhibitor compounds, and the therapeutic use thereof |
| 02/12/1997 | EP0757691A1 Cephalosporin synthesis |
| 02/12/1997 | EP0604552B1 Method of synthesizing diverse collections of oligomers |
| 02/12/1997 | EP0564588B1 Hexapeptide anaphylatoxin-receptor ligands |
| 02/12/1997 | CN1142832A CS-1 peptidomimetics, compositions and methods of using the same |
| 02/12/1997 | CN1142831A Novel 2-substituted indane-2-mercaploacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 02/12/1997 | CN1142830A Macrocyclic difluorostatone derivatives useful as antiviral agents |
| 02/12/1997 | CN1142826A Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 02/12/1997 | CN1142492A Substituted N-(indole-2-carbonyl)-glycinamides and derivatives as antidiabetic agents |
| 02/11/1997 | US5602275 May be used to accelerate recovery from neutropenia accompanying radio- or chemotherapy, bone marrow transplantation or infections |
| 02/11/1997 | US5602253 Peptides derivatives |
| 02/11/1997 | US5602175 Retroviral protease inhibitors |
| 02/11/1997 | US5602155 Platelet aggregation inhibitors |
| 02/11/1997 | US5602149 1-OXO-2-(phenylsulphonylamino)pentypiperidine derivatives, their preparation and their therapeutic application |
| 02/11/1997 | US5602122 Method for lowering total serum cholesterol and treating hypercholesterolemia with aminoacetylmercapto derivatives |
| 02/11/1997 | US5602101 Antithrombotic agents |
| 02/11/1997 | US5602100 Analgesics, treating gastrointestinal disorders |
| 02/11/1997 | US5602099 δ opioid receptor antagonists |
| 02/11/1997 | US5602098 Anticancer agent |
| 02/11/1997 | US5602097 Synthetic antibiotics |
| 02/11/1997 | CA2054212C Method for polymerization of epoxide compounds |
| 02/06/1997 | WO1997004004A1 CYSTEINE PROTEASE INHIBITORS FOR USE IN TREATMENT OF IgE MEDIATED ALLERGIC DISEASES |
| 02/06/1997 | WO1997003939A1 Novel amide-based cationic lipids |
| 02/06/1997 | WO1997003783A1 Metalloproteinase inhibitors |
| 02/06/1997 | WO1997003679A1 Phosphorous-containing cysteine and serine protease inhibitors |
| 02/06/1997 | CA2227373A1 Novel amide-based cationic lipids |
| 02/06/1997 | CA2227198A1 Cysteine protease inhibitors for use in treatment of ige mediated allergic diseases |
| 02/06/1997 | CA2226414A1 Phosphorous-containing cysteine and serine protease inhibitors |
| 02/05/1997 | EP0757049A1 Camptothecin derivatives |
| 02/05/1997 | EP0756625A1 Irreversible cysteine protease inhibitors containing vinyl groups conjugated to electron withdrawing groups |
| 02/05/1997 | EP0756603A1 Multirepresentation of a peptide analogue of the dppiv substrate, especially of the kpr type, to inhibit the entry of hiv in cells |
| 02/05/1997 | EP0756602A1 Cck or gastrin modulating 5-heterocyclic-1,5-benzodiazepines |
| 02/05/1997 | CN1142228A Novel amino acid derivatives, method of producing same and pharmaceutical compositions containing these compounds |
| 02/05/1997 | CN1142184A Antiarrhythmic benzodiazepines |
| 02/04/1997 | US5599903 Glutathione analogs and paralog panels comprising glutathione mimics |
| 02/04/1997 | US5599902 Cancer inhibitory peptides |
| 02/04/1997 | US5599816 Bactericide |
| 02/04/1997 | US5599793 Anticoagulants |
| 02/04/1997 | US5599791 Bactericide active against gramnegative and grampositive bacteria |
| 02/04/1997 | US5599543 Preventing malaria |
| 02/04/1997 | CA2022874C N,n'-(1-oxo-1,2-ethanediyl)-bis-(aspartic acid), salts and use in detergent compositions |
| 01/30/1997 | WO1997003094A1 Cell adhesion inhibitors |
| 01/30/1997 | WO1997003093A1 Peptide derivatives and angiotensin iv receptor agonist |
| 01/30/1997 | WO1997003091A1 Process for preparing peptides and n-carbamoyl-protected peptides |
| 01/30/1997 | WO1996040745A3 Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases |
| 01/30/1997 | WO1996040739A3 Urethane mediated, gst specific molecular release systems |
| 01/30/1997 | WO1996035805A3 Tripeptidylpeptidase inhibitors |
| 01/30/1997 | DE19527575A1 Verfahren zur Herstellung von peptidischer Wirkstoffe Process for the preparation of active substances of peptidic |
| 01/30/1997 | CA2227732A1 Process for preparing peptides and n-carbamoyl-protected peptides |
| 01/30/1997 | CA2226868A1 Cell adhesion inhibitors |
| 01/30/1997 | CA2226303A1 Peptide derivatives and angiotensin iv receptor agonist |
| 01/29/1997 | EP0755942A1 Peptide derivative |
| 01/29/1997 | EP0755408A1 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis |
| 01/29/1997 | EP0755405A1 Phosphonyldipeptides useful in the treatment of cardiovascular diseases |
| 01/29/1997 | EP0755404A1 Tachykinin antagonists |
| 01/29/1997 | EP0755383A1 Inhibitors of farnesyl-protein transferase |
| 01/29/1997 | EP0755374A1 Process for peptide segment condensation |
| 01/29/1997 | EP0644772A4 Opioid peptides. |
| 01/29/1997 | CN1141649A Mutants of a thermostable neutral protease from bacillus |
| 01/29/1997 | CN1141636A Novel opioid peptides for treating pain, and use therefor |
| 01/28/1997 | US5597928 Retroviral protease inhibiting compounds |
| 01/28/1997 | US5597927 Retroviral protease inhibiting compounds |
| 01/28/1997 | US5597926 Retroviral protease inhibiting compounds |